FSRH response MHRA consultation Lovima as Pharmacy medicine March 2021


Published on: 4 March 2021

File size: 606kb PDF

File type: FSRH Consultation Response

We respond to the consultation by The Medicines and Healthcare Products Regulatory Agency (MHRA) on whether to reclassify Lovima, a progestogen-only contraceptive pill, as Pharmacy (P) medicine.

Your download should start automatically. If not download directly.